2855 GAZELLE COURT, CARLSBAD, CA
Market cap: $13.7B (2/08/2026)
Price: $84.79
Well-Positioned for Continued Momentum and Substantial Value Creation in 2026 with Two New Independent Launches and Several Pivotal Data Readouts
Partner announces positive topline results from B-Well 1 and B-Well 2 Phase 3 studies for bepirovirsen, a potential first-in-class medicine for chronic hepatitis
Prices Convertible Notes Offering to Refinance 2026 Convertible Notes
Olezarsen Shows Up to 72% Triglyceride Reduction in sHTG Study at AHA
Amended material disclosure
Reports Third Quarter 2025 Financial Results and Highlights Progress on Key Programs
Ionis reports positive results for zilganersen in Alexander disease, plans NDA by Q1 2026
Olezarsen Significantly Reduces Triglycerides and Acute Pancreatitis Events in Landmark Pivotal Studies for People with Severe Hypertriglyceridemia
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Amended Notice of Proposed Sale of Securities